| Literature DB >> 23620288 |
Anna Golisz1, Pawel J Sikorski, Katarzyna Kruszka, Joanna Kufel.
Abstract
Sm-like (Lsm) proteins have been identified in all organisms and are related to RNA metabolism. Here, we report that Arabidopsis nuclear AtLSM8 protein, as well as AtLSM5, which localizes to both the cytoplasm and nucleus, function in pre-mRNA splicing, while AtLSM5 and the exclusively cytoplasmic AtLSM1 contribute to 5'-3' mRNA decay. In lsm8 and sad1/lsm5 mutants, U6 small nuclear RNA (snRNA) was reduced and unspliced mRNA precursors accumulated, whereas mRNA stability was mainly affected in plants lacking AtLSM1 and AtLSM5. Some of the mRNAs affected in lsm1a lsm1b and sad1/lsm5 plants were also substrates of the cytoplasmic 5'-3' exonuclease AtXRN4 and of the decapping enzyme AtDCP2. Surprisingly, a subset of substrates was also stabilized in the mutant lacking AtLSM8, which supports the notion that plant mRNAs are actively degraded in the nucleus. Localization of LSM components, purification of LSM-interacting proteins as well as functional analyses strongly suggest that at least two LSM complexes with conserved activities in RNA metabolism, AtLSM1-7 and AtLSM2-8, exist also in plants.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23620288 PMCID: PMC3695525 DOI: 10.1093/nar/gkt296
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Arabidopsis LSM orthologs
| Protein | ID | Identity (%) | Similarity (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Hs | Sc | Dm | Os | Hs | Sc | Dm | Os | ||
| AtLSM1a | At1g19120 | 53 | 42 | 59 | 76 | 69 | 68 | 74 | 87 |
| AtLSM1b | At3g14080 | 53 | 43 | 57 | 80 | 71 | 67 | 74 | 92 |
| AtLSM2 | At1g03330 | 76 | 67 | 78 | 92 | 86 | 78 | 86 | 98 |
| AtLSM3a | At1g21190 | 80 | 43 | 75 | 90 | 94 | 65 | 94 | 99 |
| AtLSM3b | At1g76860 | 80 | 48 | 78 | 94 | 92 | 67 | 92 | 98 |
| AtLSM4 | At5g27720 | 87 | 40 | 77 | 79 | 96 | 58 | 87 | 82 |
| AtLSM5 | At5g48870 | 75 | 45 | 70 | 94 | 88 | 67 | 86 | 95 |
| AtLSM6a | At2g43810 | 85 | 43 | 77 | 89/90 | 93 | 52 | 87 | 95/96 |
| AtLSM6b | At3g59810 | 85 | 41 | 82 | 89/90 | 91 | 52 | 88 | 91/92 |
| AtLSM7 | At2g03870 | 55 | 47 | 61 | 90 | 79 | 70 | 82 | 96 |
| AtLSM8_short | At1g65700 | 62 | 28 | 61 | 84 | 80 | 53 | 78 | 92 |
| AtLSM8_long | At1g65700 | 43 | 26 | 42 | 58 | 55 | 49 | 53 | 64 |
Hs, H.sapiens; Sc, S.cerevisiae; Dm, D. melanogaster; Os, Oryza sativa.
aTwo LSM6 proteins encoded in the Oryza genome.
Figure 1.Expression of AtLSM genes in A. thaliana. Semi-quantitative RT-PCR analysis of AtLSM in leaves (Lv), stems (St), flowers (Fl), siliques (Sl) and roots (Rt). For AtLSM8, both short and long mRNA versions are detected. M, DNA ladder. Elongation factor elF-4A was used as a control.
Figure 2.Distribution of AtLSM proteins in subcellular fractions of AtLSM1-SF-TAP, AtLSM5-SF-TAP and AtLSM8-SF-TAP transgenic lines. Nuclei and cytoplasm were separated by fractionation, and similar cell equivalents were subjected to SDS-PAGE followed by western blotting using the indicated antibodies. Histone H3 and Phosphoenolpyruvate carboxylase (PEPC) were used as nuclear and cytoplasmic markers, respectively. T, total; C, cytoplasm; N, nucleus.
Set of proteins present in at least two of three independent purifications that were specifically bound to anti-FLAG-M2 resin, as identified by tandem mass spectrometry following subtraction of peptides present in respective controls to account for unspecific hits
| AGI no. | Description | Number of times identified | Biological process/molecular function |
|---|---|---|---|
| AtLSM1a and co-purified proteins | |||
| At1g19120 | Small nuclear RNP family protein AtLSM1a | 3 | mRNA processing |
| At1g03330 | Small nuclear RNP family protein AtLSM2 | 3 | mRNA processing & mRNA splicing |
| At1g21190 | Small nuclear RNP family protein AtLSM3a | 3 | mRNA processing & mRNA splicing |
| At1g76860 | Small nuclear RNP family protein AtLSM3b | 3 | mRNA processing & mRNA splicing |
| At5g27720 | Small nuclear RNP family protein AtLSM4 | 3 | mRNA processing & mRNA splicing |
| At5g48870 | Small nuclear RNP family protein SAD1/AtLSM5 | 3 | mRNA processing & mRNA splicing |
| At2g43810 | Small nuclear RNP family protein AtLSM6a | 3 | mRNA processing & mRNA splicing |
| At3g59810 | Small nuclear RNP family protein AtLSM6b | 3 | mRNA processing & mRNA splicing |
| At2g03870 | Small nuclear RNP family protein AtLSM7 | 3 | mRNA processing & mRNA splicing |
| At3g22270 | Topoisomerase II-associated protein PAT1 | 3 | Putative role in mRNA decapping |
| At4g14990 | Topoisomerase II-associated protein PAT1 | 3 | Putative role in mRNA decapping |
| At1g79090 | Topoisomerase II-associated protein PAT1 | 3 | Putative role in mRNA decapping |
| At2g23350 | poly(A) binding protein 4 (PABP4) | 3 | Response to cadmium ion/RNA binding |
| At1g01320 | Tetratricopeptide repeat–like superfamily protein | 2 | mRNA modification |
| At1g02080 | Transcription regulator | 2 | Putative component of the CCR4-NOT transcription complex and cytoplasmic deadenylase complex |
| At3g13300 | Transducin/WD40 repeat-like superfamily protein VCS | 2 | mRNA decapping enhancer |
| At3g11500 | Small nuclear RNP family protein, putative homologue of yeast and human SmG | 2 | Putative role in mRNA splicing |
| At2g45810 | DEA(D/H)-box RNA helicase family protein | 2 | Nucleic acid binding/putative role in mRNA processing |
| At1g22760 | poly(A) binding protein 3 (PABP3) | 2 | mRNA processing |
| AtLSM8 and co-purified proteins | |||
| At1g03330 | Small nuclear RNP family protein AtLSM2 | 3 | mRNA processing & mRNA splicing |
| At1g21190 | Small nuclear RNP family protein AtLSM3a | 3 | mRNA processing & mRNA splicing |
| At1g76860 | Small nuclear RNP family protein AtLSM3b | 3 | mRNA processing & mRNA splicing |
| At5g27720 | Small nuclear RNP family protein AtLSM4 | 3 | mRNA processing & mRNA splicing |
| At5g48870 | Small nuclear RNP family protein SAD1/AtLSM5 | 3 | mRNA processing & mRNA splicing |
| At2g43810 | Small nuclear RNP family protein AtLSM6a | 3 | mRNA processing & mRNA splicing |
| At3g59810 | Small nuclear RNP family protein AtLSM6b | 3 | mRNA processing & mRNA splicing |
| At2g03870 | Small nuclear RNP family protein AtLSM7 | 3 | mRNA processing & mRNA splicing |
| At1g65700 | Small nuclear RNP family protein AtLSM8 | 3 | mRNA splicing |
| At4g24270 | Embryo defective 140 (EMB140), putative homologue of yeast/human Prp24/SART3(p110) | 3 | RNA processing/putative role in mRNA splicing |
| At2g23350 | poly(A) binding protein 4 (PABP4) | 3 | Response to cadmium ion/RNA binding |
| At3g11500 | Small nuclear RNP family protein, putative homologue of yeast and human SmG | 3 | Putative role in mRNA splicing |
| At3g61240 | DEA(D/H)-box RNA helicase family protein | 3 | Nucleotide biosynthetic process/putative role in mRNA processing |
| At5g07350 | TUDOR-SN protein 1 (TSN1) | 2 | Gene silencing by RNA |
| At5g14140 | Zinc ion binding/nucleic acid binding | 2 | Putative role in regulation of transcription |
| At1g20960 | Embryo defective 1507 (EMB1507), putative homologue of yeast/human Brr2(Prp44)/SNRNP200 | 2 | Nucleotide biosynthetic process/nucleic acid binding |
| At5g61780 | TUDOR-SN protein 2 (TSN2) | 2 | Gene silencing by RNA |
| At1g80070 | Embryo defective 14 (EMB14), putative homologue of yeast and human PRP8 | 2 | Putative role in mRNA splicing |
| At3g07590 | Small nuclear RNP family protein, putative homologue of yeast and human SmD1 | 2 | Putative role in mRNA splicing |
| At1g01320 | Tetratricopeptide repeat–like superfamily protein | 2 | mRNA modification |
| At2g25910 | 3′–5′ exonuclease domain-containing protein | 2 | Nucleobase-containing compound metabolic process/RNA binding |
aThe biological process/molecular function listed are mainly according to TAIR (http://www.arabidopsis.org/).
Figure 3.Characterization of lsm1a lsm1b and lsm8 mutant lines. (A) Structure of the AtLSM1a (At1g19120), AtLSM1b (At3g14080) and AtLSM8 (At1g65700) genes. Exons are represented by grey bars, the localization of T-DNA insertions are indicated. (B) Thirty-day-old wild-type, lsm1a lsm1b and lsm8 plants. (C) Northern analysis of AtLSM1a, AtLSM1b and AtLSM8 levels. elF-4A mRNA was used as a loading control.
Figure 4.Venn diagrams representing the number of transcripts significantly (>1.5-fold) upregulated (A), downregulated (B) or stabilized upon cordycepin treatment (C) in lsm1a lsm1b, lsm8 and sad1/lsm5 mutants. Circular diagrams (D) illustrating functional classification of transcripts upregulated or downregulated in lsm1a lsm1b, lsm8 and sad1/lsm5 mutants. Results were obtained from the PageMan database (https://http://mapman.mpimpgolm.mpg.de/index.shtml). (E) Validation of microarray data for chosen transcripts. Northern analysis of At3g17520, At3g02480, At5g66400 (RAB18), At5g55450, At1g64110 (DAA1), At2g18050 (HIS1-3) in lsm1a lsm1b, lsm8 and sad1/lsm5 mutants and their respective wild types (Col-0 or WT). Numbers in parentheses represent the transcript level in the mutant relative to Col-0 or wild type, respectively. eIF-4A was used as a loading control.
Figure 6.AtLSM1 and AtLSM5 affect mRNA stability. Northern analysis of mRNAs, including XRN4 or DCP2 substrates and ARE- and DST-containing transcripts, at specific time points after cordycepin treatment in lsm1a lsm1b (A) and sad1/lsm5 (B) mutants and their respective wild types (Col-0 or WT). Estimated mRNA half-life (t1/2) is shown to the right of each panel. Numbers in parentheses represent the fold change in the transcript level of the mutant versus wild type for those mRNAs that accumulate at the steady state (at time 0’ min). elF-4A mRNA was used as control.
Figure 7.AtLSM1 and AtLSM5 affect mRNA stability. Description is as for Figure 6.
Figure 8.Northern analysis of mRNAs, which stability is altered in lsm8 (A), lsm1a lsm1b (B), xrn4-5 (C) and xrn3-8 (D) mutants. Description is as for Figure 6, except that elF-4A or 18S rRNA were used as controls.
Figure 5.AtLSM5 and AtLSM8 are involved in pre-mRNA splicing. (A) Northern analysis of U6 snRNA in lsm1a lsm1b, lsm8 and sad1/lsm5 mutants and their respective wild types (Col-0 or WT). Numbers in parentheses represent the transcript level in the mutant relative to Col-0 or wild type, respectively. 5S rRNA was used as a loading control. (B) RNA immunoprecipitation. RNA IP was performed on nuclear extracts from lsm8 expressing AtLSM8-SF-TAP or Col-0 plants using anti-FLAG resins. U6 snRNA and 25S rRNA were detected by semi-quantitative RT-PCR in the input and IP fractions. –RT, reverse-transcription reaction control using U6 primers. (C) Semi-quantitative RT-PCR and quantitative RT-PCR analyses of intron retention in sad1/lsm5 and lsm8 mutants and their respective wild types (Col-0 or WT). Specific primers used to detect At3g17250 (PP2C), At4g26080 (ABI1) and At5g59220 (HAI1) are depicted to the right of each panel. eIF-4A was used as a control. (D) Semi-quantitative RT-PCR for genes involved in splicing. Specific primers used to detect SRp30, SRp31a, SRp34a, RSp40, U1-70K were located in the first and last exons. eIF-4A was used as a control.
Figure 9.mRNAs stabilized in lsm mutants are 5′ capped. Immunoprecipitation of total RNAs with monoclonal anti-cap antibodies followed by qRT-PCR analysis of selected AtLSM1 (At4g11280, At5g62520, At5g12020, At4g32020), AtLSM8 (At4g11280, At5g62520) and AtXRN4 (At4g11280, At5g62520, At4g32020) substrates. Histograms represent the level of immunoprecipitated transcripts, where the value for Col-0 was arbitrarily set to 100. Values with standard deviations (±SD) were obtained from three independent experiments; *P < 0.05, **P < 0.01, ***P < 0.001.